Latest News

Cancer in the blood outbreak and treatment for malignant cells in a human body caused by carcinogens and genetics with a cancerous cell as an immunotherapy and leukemia or lymphoma symbol and medical | Image Credit: © freshidea - stock.adobe.com
Multiple Myeloma Treatment from Regeneron Gets FDA Accelerated Approval

July 2nd 2025

Linvoseltamab-gcpt, marketed as Lynozyfic, is a bispecific antibody designed to facilitate T cell activation and cancer cell killing.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
EDQM Announces Digital Version of the European Pharmacopoeia

June 26th 2025

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
EMA Conditionally Authorizes Stem Cell Therapy for Blood Cancers

June 23rd 2025

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | Image Credit: © Tada Images - stock.adobe.com
FDA Halts Clinical Trials That Send US Patient Cells to Foreign Labs

June 20th 2025

Bioreactor. Cultivation of microorganisms in the bioreactor. Laboratory fermenter. Microbial fermentation. The creation of drugs. Microbiology. Biotech industry. Pharmacology. | Image Credit: © Grispb - stock.adobe.com
Aragen to Commence GMP Manufacturing at India Biologics Facility in July 2025

June 16th 2025

Digitalization of QbD Risk Assessments

The digital transformation of quality-by-design assessment workflows can improve efficiency, reduce human errors, and facilitate integration within a much broader digital ecosystem.

Digitalization of QbD Risk Assessments; Image: photon_photo  - stock.adobe.com

More News

© 2025 MJH Life Sciences

All rights reserved.